Aytu BioScience Earning Date (AYTU)

USA |NASDAQ |USD

AYTU Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Sep 26, 2022 Jun 2022 - - $-0.81
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Sep 26, 2022 Jun 2022 - - $23.48M

Aytu Bioscience's next earnings date is Monday, Sep 26, 2022 for the fiscal quarter ending Jun 2022.

AYTU Earnings Date & History Chart

AYTU Earnings & Revenue Forecast

AYTU Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 1 $-1.70 $-1.70 $-1.70
Jun 2023 1 $-1.07 $-1.07 $-1.07

AYTU Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 0 / 0 $-0.96 $-0.55 $-0.55
Jun 2023 1 / 0 $-0.31 $1.06 $1.06

AYTU Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 1 $106.80M $106.80M $106.80M
Jun 2023 1 $118.50M $118.50M $118.50M

AYTU Earnings Date & Revenue History

AYTU Earnings History

|
Show More
Show More

AYTU Revenue History

|
Show More
Show More

Aytu Bioscience Next Earnings Date & Report

AYTU Next Earnings Date & Report Preview: Jun 2022 (FQ)

AYTU's next earnings date is Monday, Sep 26, 2022 for the fiscal quarter ending Jun 30, 2022.

Aytu Bioscience Previous Earnings Dates & Reports

AYTU Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Aytu Bioscience's previous earnings date was May 16, 2022 for its fiscal quarter ended Mar 31, 2022.

AYTU Previous Earnings Date & Report Recap: Jun 2021 (FY)

Aytu Bioscience's previous annual earnings date was Sep 27, 2021 for its fiscal year ended Jun 30, 2021.

AYTU's earnings per share (EPS) was $-3.24, missing the consensus analysts forecast of $-2.44 by 32.79% , and higher than the previous year's EPS (Jun 2020) by -35.20%.

Revenues were $65.63M, better than the forecast of $62.65M by 4.76%, and up by 137.52% from previous year's revenue.

The company reported a net income of $-58.29M.

Aytu Bioscience reported a free cash flow of $-25.96M for its fiscal year, compared to $-28.37M a year ago.

The company ended the fiscal year with $28.35M in total debt, an increase of 1025.79% compared to the previous year.